French data is current through early September 2018. All of the data comes from L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and France.
데이터 추가 비고
조치
In agreement with AFSSAPS, the company Depuy proceeded on December 24, with the removal of all the batches of the range of trochanteric nails ACE ATN. On this day the 16 health institutions concerned by this withdrawal received the attached letter (24/12/2003) (20 KB). The withdrawal is global. This decision of withdrawal intervenes following 3 cases of migration of cervico-cephalic screws in the abdominal cavity. No cases have been reported in France. Depuy SA recommends that surgeons perform a clinical and radiological follow-up of implanted patients, especially at three months and until the fracture is consolidated.